Filing Details
- Accession Number:
- 0001962918-25-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-19 17:55:47
- Reporting Period:
- 2025-03-17
- Filing Date:
- 2025-03-19
- Accepted Time:
- 2025-03-19 17:55:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1962918 | Acelyrin Inc. | SLRN | Pharmaceutical Preparations (2834) | 852406735 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2023809 | Shephard Mpofu | C/O Acelyrin, Inc. 4149 Liberty Canyon Rd. Agoura Hills CA 91301 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-03-17 | 3,211 | $2.74 | 121,789 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to the Issuer's policy requiring sell-to-cover to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlementof certain Restricted Stock Units, and does not represent a discretionary sale by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices no more than $2.76 and no less than $2.71, inclusive. The Reporting Personundertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at eachseparate price within the range set forth in this footnote.
Billionaire Hedge Funds
